A critical appraisal of sedation, analgesia and delirium in neurocritical care.
Administering analgesics, sedatives and antipsychotics is challenging in the Neurological Intensive Care Unit (NICU). We reviewed this literature and our current practice to better inform the critical care practitioner and to identify gaps for future research. We electronically searched observational, intervention and outcome studies addressing sedation, analgesia and delirium in the NICU, and their bibliographies. Practice patterns were assessed in three critical care units with specialized neurological care in Montreal. Bedside pain assessment tools are psychometrically validated in the neuro-critically ill but sedation and delirium tools are not. Rigorous pain and sedation assessments appear feasible; delirium screening has not been tested. Publications addressing outcomes and responses to pharmacologic treatment lack consistency, rigor or both. In daily practice, pharmacologic management varies greatly. Clearly, little information exists on analgesia, sedation and delirium in the NICU. Systematic evaluation of pain improves outcome. No evidence-based therapeutic recommendations can be proffered.
Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Jeanne S
JS
Teitelbaum
Omar
O
Ayoub
Yoanna
Y
Skrobik
D000698:Analgesia / Q000009:adverse effects*; D003693:Delirium / Q000139:chemically induced* / Q000628:therapy*; D006801:Humans; D006993:Hypnotics and Sedatives; D007362:Intensive Care Units / Q000592:standards / Q000639:trends; D010146:Pain / Q000188:drug therapy*; D010147:Pain Measurement; D012307:Risk Factors
D006993:Hypnotics and Sedatives